Latest Chikungunya Stories
Under the watchful eye of ESA’s Vecmap initiative, the Asian bush mosquito is about to get bitten in Belgium.
Recent breakthroughs in Chikungunya research spearheaded by scientists at A*STAR’s Singapore Immunology Network (SIgN) have made great strides in the battle against the infectious disease.
Researchers have developed a new candidate vaccine to protect against chikungunya virus, a mosquito-borne pathogen that produces an intensely painful and often chronic arthritic disease that has stricken millions of people in India, Southeast Asia and Africa.
An experimental research carried out in Sant Cugat del VallÃ¨s and RubÃ, coordinated by researchers from UAB, assessed the efficacy of a combination of strategies to reduce the population of tiger mosquitos (Aedes albopictus).
The ten studies in this special issue document the substantial and growing burden of dengue in the Americas, Africa and Asia, and the burden of a chikungunya outbreak in India.
JAKARTA, Indonesia, June 14, 2011 /PRNewswire/ -- The Association of Southeast Asian Nations (ASEAN) launched the first ASEAN Dengue Day today in Indonesia, with related events occurring throughout the ASEAN member states.
What causes a virus to suddenly begin infecting large numbers of people?
MENLO PARK, Calif., May 5, 2011 /PRNewswire/ -- In parts of the world where dengue fever is common, other viral infections are often misdiagnosed. Such misdiagnosis is a waste not only of time and money.
The Singapore Immunology Network (SIgN), an institute of the Agency of Science, Technology and Research (A*STAR), and VIVALIS (NYSE Euronext: VLS), a French biopharmaceutical company, announced today the discovery of two new fully human monoclonal antibodies which could battle Chikungunya, a disease that currently has no available vaccine or specific treatment.
- Sleep; the state or condition of being asleep.
- The state or condition of numbness of a part due to pressure on a nerve: as, the obdormition of a limb.